Impact of multiple malignancies on surgical outcomes in patients with 1 cm or smaller non-small cell lung cancer

被引:1
|
作者
Tsukioka, Takuma [1 ]
Izumi, Nobuhiro [1 ]
Mizuguchi, Shinjiro [1 ]
Kyukwang, Chung [1 ]
Komatsu, Hiroaki [1 ]
Toda, Michihito [1 ]
Hara, Kantaro [1 ]
Miyamoto, Hikaru [1 ]
Nishiyama, Noritoshi [1 ]
机构
[1] Osaka City Univ Hosp, Dept Thorac Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan
关键词
Non-small cell lung cancer; Multiple malignancies; Treatment interval; Prognostic factor; RECURRENCE; CARCINOMA; SURVIVAL; LESS;
D O I
10.1007/s10147-017-1185-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Because most patients with small-sized non-small cell lung cancer (NSCLC) are asymptomatic, their lesions are detected by cancer screenings or routine checkups for other diseases. Incidences of multiple malignancies have been reported to be 27% in patients with stage I-III NSCLC. Some patients have treatment histories for other malignancies, and their small-sized NSCLC was incidentally detected during follow-up. There is no established report regarding the influence of multiple malignancies on small-sized NSCLC prognosis. Therefore, we investigated the correlation between multiple malignancies and surgical outcomes in patients with small-sized NSCLC. In total, 44 patients underwent definitive pulmonary resection for NSCLC of 1 cm or smaller between January 2003 and December 2012. Tumor size was measured by macroscopic findings of the resected specimens, and we then retrospectively investigated their clinical courses. One patient had hemoptysis symptoms, whereas 43 patients were asymptomatic; among them, NSCLC was detected by examinations for other diseases in 31 patients and by cancer screening in 12 patients. In total, 20 patients (45%) had multiple malignancies. The median follow-up period was 68 months. One patient had a recurrence from current NSCLC. No patients died of current NSCLC. The overall 5-year survival rate was 90% for all patients. Patients with multiple malignancies had significantly poorer prognoses compared with those without multiple malignancies (P = 0.016). However, patients with treatment intervals of more than 5 years had prognoses equivalent to those of patients without multiple malignancies (P = 0.829). Only the presence of multiple malignancies was a significantly poor prognostic factor in univariate and multivariate analyses. NSCLC of 1 cm or smaller showed good prognoses. The presence of multiple malignancies was a significantly poor prognostic factor, and short treatment intervals also correlated with poor prognosis.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [1] Impact of multiple malignancies on surgical outcomes in patients with 1 cm or smaller non-small cell lung cancer
    Takuma Tsukioka
    Nobuhiro Izumi
    Shinjiro Mizuguchi
    Chung Kyukwang
    Hiroaki Komatsu
    Michihito Toda
    Kantaro Hara
    Hikaru Miyamoto
    Noritoshi Nishiyama
    International Journal of Clinical Oncology, 2018, 23 : 66 - 72
  • [2] Surgical Outcomes in Resected Non-small Cell Lung Cancer ≤ 1 cm in Diameter
    Wang, Bing-Yen
    Hung, Jung-Jyh
    Jeng, Wen-Juei
    Hsu, Wen-Hu
    Hsieh, Chih-Cheng
    Huang, Min-Hsiung
    Huang, Biing-Shiun
    Liu, Jung-Sen
    Wu, Yu-Chung
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2010, 73 (06) : 308 - 313
  • [3] Multiple Primary Malignancies in Patients with Non-Small Cell Lung Cancer
    Fujita, Shiro
    Masago, Katsuhiro
    Takeshita, Jumpei
    Togashi, Yosuke
    Hata, Akito
    Kaji, Reiko
    Kokubo, Masaki
    Katakami, Nobuyuki
    INTERNAL MEDICINE, 2015, 54 (03) : 325 - 331
  • [4] Impact of previous extra-pulmonary malignancies on surgical outcomes of sequential primary non-small cell lung cancer
    Zhang, Chenxi
    Tang, Xiyang
    Liu, Wenhao
    Zheng, Kaifu
    Li, Xiaofei
    Ma, Nan
    Zhao, Jinbo
    HELIYON, 2023, 9 (07)
  • [5] The Prognostic Impact of Cigarette Smoking on Patients with Non-small Cell Lung Cancer
    Maeda, Ryo
    Yoshida, Junji
    Ishii, Genichiro
    Hishida, Tomoyuki
    Nishimura, Mitsuyo
    Nagai, Kanji
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (04) : 735 - 742
  • [6] Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung Cancer
    Olive, Jacqueline K.
    Zhou, Nicolas
    Mitchell, Kyle G.
    Corsini, Erin M.
    Hofstetter, Wayne L.
    Mehran, Reza J.
    Rice, David C.
    Sepesi, Boris
    Swisher, Stephen G.
    Vaporciyan, Ara A.
    Walsh, Garrett L.
    Antonoff, Mara B.
    ANNALS OF THORACIC SURGERY, 2022, 113 (03) : 1008 - 1014
  • [7] Outcomes in Thoracic Surgical Management of Non-Small Cell Lung Cancer
    von Ballmoos, Moritz C. Wyler
    Johnstone, David W.
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (05) : 539 - 542
  • [8] Impact of race on outcomes of patients with non-small cell lung cancer
    Bryant, Ayesha S.
    Cerfolio, Robert James
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (07) : 711 - 715
  • [9] Treatment outcomes for Patients with synchronous multiple primary non-small cell lung cancer
    Jung, Eun Jung
    Lee, Jong Hoo
    Jeon, Kyeongman
    Koh, Won-Jung
    Suh, Gee Young
    Chung, Man Pyo
    Kim, Hojoong
    Kwon, O. Jung
    Shim, Young Mog
    Um, Sang-Won
    LUNG CANCER, 2011, 73 (02) : 237 - 242
  • [10] Surgical Outcomes in Patients With Centrally Located Non-small Cell Lung Cancer
    Tsukioka, Takuma
    Izumi, Nobuhiro
    Komatsu, Hiroaki
    Inoue, Hidetoshi
    Matsuda, Yumi
    Ito, Ryuichi
    Kimura, Takuya
    Nishiyama, Noritoshi
    IN VIVO, 2021, 35 (05): : 2815 - 2820